Clorox

Capital deployment has prioritized organic investment, digital transformation, and dividends, with targeted portfolio moves. FY2025 capex was 220 million (~3.1 percent of sales) as the company invests in ERP and productivity.

The multi‑year digital program (570 to 580 million, roughly 75 percent expensed and about 70 percent ERP-related) should yield long‑term efficiencies. Management divested the Better Health VMS business and previously exited Argentina to streamline focus.

Share repurchases resumed in FY2025 after several years of pause, and the company maintained its multi‑decade dividend growth streak, raising the quarterly dividend to 1.24. On the cautious side, the VMS acquisition several years ago ultimately proved noncore and the 2026 Glad buyout is a sizable cash call.

Overall, allocation is improving and disciplined, with an emphasis on returns and simplification.